Histopathological study of the treatment of melasma lesions using a low-fluence Q-switched 1064-nm neodymium:yttrium-aluminium-garnet laser

J. E. Kim, S. E. Chang, U. C. Yeo, S. Haw, I. H. Kim

    Research output: Contribution to journalArticlepeer-review

    40 Citations (Scopus)

    Abstract

    The low-fluence 1064-nm Q-switched neodymium:yttrium-aluminium-garnet (QSNY) laser is a widely used treatment for melasma in East Asia, although its mechanism of action is unclear. The aim of this study was to elucidate the mechanism of action of the QSNY laser. We performed a histopathological study on eight Korean women who had considerable improvement in their melasma lesions after a series of low-fluence QSNY laser treatments. Compared with nonlesional skin, samples from melasma lesions showed increased reactivity in melanin (Fontana-Masson staining) and in melanogenesis-associated proteins, including α-melanocyte-stimulating hormone, tyrosinase, tyrosinase-related protein (TRP)-1, TRP-2, nerve growth factor and stem cell factor. After laser treatment, the melasma skin showed a decrease in the number of melanosomes and reduced expression of melanogenesis-associated proteins. Expression levels of the melanogenic proteins were reduced after laser treatment, although the number of melanocytes was unchanged even in hypopigmented areas. Based on these results, we believe that repeated application of low thermal energy via QSNY laser may result in damage to melanocytes and long-lasting hypopigmentation.

    Original languageEnglish
    Pages (from-to)167-171
    Number of pages5
    JournalClinical and Experimental Dermatology
    Volume38
    Issue number2
    DOIs
    Publication statusPublished - 2013 Mar

    ASJC Scopus subject areas

    • Dermatology

    Fingerprint

    Dive into the research topics of 'Histopathological study of the treatment of melasma lesions using a low-fluence Q-switched 1064-nm neodymium:yttrium-aluminium-garnet laser'. Together they form a unique fingerprint.

    Cite this